Log in or register to see all Alerts
New HTA Decisions in England
March 2021
Drug name
Brinavess (vernakalant)
Company
Correvio Ltd
Decision date
//
Therapeutic area
Cardiovascular conditions
Therapeutic sub area
Heart rhythm conditions
Decision
Not recommended
Indication
Vernakalant (Brinavess) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.
Decision Detail
This was a terminated appraisal.
Summary
NICE was unable to make a recommendation on vernakalant (Brinavess) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults because the company did not provide an evidence submission. NICE will review this decision if the company decides to make a submission.